Virtu Financial’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.67M | Sell |
3,175
-1,462
| -32% | -$768K | 0.09% | 209 |
|
2025
Q1 | $2.94M | Buy |
4,637
+343
| +8% | +$218K | 0.16% | 76 |
|
2024
Q4 | $3.06M | Sell |
4,294
-1,760
| -29% | -$1.25M | 0.16% | 104 |
|
2024
Q3 | $6.36M | Buy |
+6,054
| New | +$6.36M | 0.35% | 37 |
|
2023
Q3 | – | Sell |
-9,431
| Closed | -$6.78M | – | 1784 |
|
2023
Q2 | $6.78M | Buy |
+9,431
| New | +$6.78M | 0.52% | 23 |
|
2023
Q1 | – | Sell |
-315
| Closed | -$227K | – | 1998 |
|
2022
Q4 | $227K | Buy |
+315
| New | +$227K | 0.03% | 639 |
|
2022
Q3 | – | Sell |
-11,126
| Closed | -$6.58M | – | 2145 |
|
2022
Q2 | $6.58M | Buy |
+11,126
| New | +$6.58M | 0.56% | 22 |
|
2021
Q4 | – | Sell |
-1,500
| Closed | -$908K | – | 2099 |
|
2021
Q3 | $908K | Buy |
+1,500
| New | +$908K | 0.08% | 260 |
|
2021
Q2 | – | Sell |
-483
| Closed | -$229K | – | 1983 |
|
2021
Q1 | $229K | Buy |
+483
| New | +$229K | 0.02% | 997 |
|
2020
Q4 | – | Sell |
-902
| Closed | -$505K | – | 1731 |
|
2020
Q3 | $505K | Buy |
+902
| New | +$505K | 0.09% | 283 |
|
2019
Q4 | – | Sell |
-2,055
| Closed | -$570K | – | 1774 |
|
2019
Q3 | $570K | Sell |
2,055
-4,648
| -69% | -$1.29M | 0.04% | 466 |
|
2019
Q2 | $2.1M | Buy |
6,703
+5,767
| +616% | +$1.81M | 0.12% | 122 |
|
2019
Q1 | $384K | Buy |
+936
| New | +$384K | 0.02% | 673 |
|
2018
Q4 | – | Sell |
-583
| Closed | -$236K | – | 1906 |
|
2018
Q3 | $236K | Buy |
+583
| New | +$236K | 0.01% | 979 |
|
2018
Q1 | – | Sell |
-9,233
| Closed | -$3.47M | – | 2479 |
|
2017
Q4 | $3.47M | Buy |
9,233
+6,968
| +308% | +$2.62M | 0.18% | 74 |
|
2017
Q3 | $1.01M | Buy |
+2,265
| New | +$1.01M | 0.05% | 445 |
|
2016
Q4 | – | Sell |
-1,317
| Closed | -$529K | – | 538 |
|
2016
Q3 | $529K | Buy |
+1,317
| New | +$529K | 0.09% | 187 |
|
2016
Q1 | – | Sell |
-1,677
| Closed | -$910K | – | 489 |
|
2015
Q4 | $910K | Buy |
+1,677
| New | +$910K | 0.13% | 158 |
|
2015
Q3 | – | Sell |
-1,957
| Closed | -$998K | – | 370 |
|
2015
Q2 | $998K | Buy |
+1,957
| New | +$998K | 0.09% | 145 |
|
2015
Q1 | – | Sell |
-1,033
| Closed | -$424K | – | 357 |
|
2014
Q4 | $424K | Sell |
1,033
-383
| -27% | -$157K | 0.05% | 206 |
|
2014
Q3 | $510K | Buy |
+1,416
| New | +$510K | 0.05% | 175 |
|
2014
Q1 | – | Sell |
-1,111
| Closed | -$306K | – | 416 |
|
2013
Q4 | $306K | Buy |
+1,111
| New | +$306K | 0.03% | 196 |
|